Clinical trials
Completed Dwarfism, Pituitary trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
162 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 5 |
| 2002 | 5 |
| 2003 | 14 |
| 2004 | 11 |
| 2005 | 12 |
| 2006 | 6 |
| 2007 | 12 |
| 2008 | 8 |
| 2009 | 8 |
| 2010 | 9 |
| 2011 | 8 |
| 2012 | 3 |
| 2013 | 6 |
| 2014 | 6 |
| 2015 | 8 |
| 2016 | 4 |
| 2017 | 7 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 162 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 23 |
| Merck KGaA, Darmstadt, Germany | 9 |
| Pfizer | 9 |
| Federico II University | 6 |
| Massachusetts General Hospital | 5 |
| Ascendis Pharma Endocrinology Division A/S | 4 |
| Eli Lilly and Company | 4 |
| LG Life Sciences | 4 |
| OPKO Health, Inc. | 4 |
| University of Aarhus | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dwarfism, Pituitary | 162 |
| Dwarfism | 11 |
| Pituitary Diseases | 9 |
| Endocrine System Diseases | 8 |
| Hypopituitarism | 7 |
| Insulin Resistance | 7 |
| Turner Syndrome | 7 |
| Failure to Thrive | 6 |
| Acromegaly | 5 |
| Kidney Failure, Chronic | 4 |
Trials
Showing 1 to 25 of 162. Each trial links to its page on Pharma Observatory.
62 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.